LifeStance Health (LFST) Share-based Compensation (2020 - 2026)

LifeStance Health (LFST) has reported Share-based Compensation for 7 consecutive years, with $128.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation rose 591.57% year-over-year to $128.5 million; the TTM figure through Mar 2026 stood at $128.5 million (up 6535.7% YoY), while the FY2025 annual figure was $107.6 million, down 3.87% from the prior year.
• Share-based Compensation improved to $128.5 million in Q1 2026 per LFST's latest filing, from $16.7 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $187.0 million in Q4 2022 and bottomed at -$60.0 million in Q4 2024.
• Historically, Share-based Compensation has averaged $45.9 million across 5 years, with a median of $23.9 million in 2023.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 9793.39% — and 2024, when it plunged 386.94%.
• LifeStance Health's Share-based Compensation stood at $187.0 million in 2022, then sank by 88.81% to $20.9 million in 2023, then tumbled by 386.94% to -$60.0 million in 2024, then jumped by 127.83% to $16.7 million in 2025, then surged by 669.4% to $128.5 million in 2026.
• Business Quant data shows LFST's Share-based Compensation at $128.5 million in Q1 2026, $16.7 million in Q4 2025, and $18.3 million in Q3 2025.